Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Cohort Study on the Effect of Clonal Hematopoiesis on Prognosis in Patients With Myocardial Infarction Based on Residual Inflammation Risk

NCT06156319 is registered in ClinicalTrials.gov with Yang Jing as lead sponsor.

NCT NCT06156319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06156319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Cohort Study on the Effect of Clonal Hematopoiesis on Prognosis in Patients With Myocardial Infarction Based on Residual Inflammation Risk
Lead sponsor
Yang Jing
Phase
Observational
Overall status
Unknown status
Start date
December 20, 2023
Completion date
June 20, 2025
Enrollment
500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

to investigate the effect of chip on renal insufficiency in ami patients